2 Million+
Cardiac Cases Annually
1.2 Million+
Life Altering Complications
70k+
Deaths Annually
Up To
55%
Preventable Deaths
Up To
20%
From Tamponade
Up To
20%
From Poor Myocardial Protection
Prof. Michael Borger, MD PhD
Dr. Fabio De Robertis
Patient’s husband
For Patients
At Fallouh Healthcare, our mission is to empower clinicians with advanced, practical solutions that improve outcomes for patients undergoing cardiothoracic surgery. What sets our technologies apart is their origin — developed by a team with direct, hands-on experience in delivering care at the heart of the surgical journey. Every innovation we create is designed with one goal in mind: to support better, safer, and more effective treatment for every patient.
For Clinicians
Founded by a practicing cardiothoracic surgeon, our work is driven by a deep understanding of the daily challenges faced in clinical settings — challenges that are often overlooked or difficult to solve. At Fallouh Healthcare, we transform these real-world problems into practical, high-impact innovations. That’s why clinicians across the globe connect with our vision and are eager to adopt our solutions — to improve care, enhance outcomes, and advance the future of surgery.
For Investors
At Fallouh Healthcare, innovation starts where it matters most — in the operating room. Founded by a practicing cardiothoracic surgeon, we’re tackling the overlooked, high stakes challenges that clinicians face every day. Our solutions aren’t theoretical — they’re born from firsthand experience and engineered for immediate impact in surgical care. With global clinical interest, award-winning technologies, and a clear path to market, Fallouh Healthcare is positioned at the forefront of a new era in cardiothoracic innovation. We invite forward-thinking investors to partner with us in transforming outcomes, reducing healthcare burdens, and shaping the future of surgical excellence.
Hazem Fallouh, MD, PhD, FRCS Consultant Surgeon CEO
- 20+ years CT Surgery
- Inventor and Entrepreneur
- PhD in Cardioplegia
- Chair of the AI & Innovation Committee EACTS
Read More
Dr. Hazem Fallouh is the CEO of Fallouh Healthcare and the inventor of the PerDeCT device and
STHpol cardioplegia solution. A consultant cardiothoracic surgeon with a distinguished career in
the NHS, Dr. Fallouh combines frontline clinical expertise with a passion for medical
innovation. He leads the company’s clinical evidence generation strategy, overseeing the design
and execution of preclinical and clinical investigations.
Dr. Fallouh also drives international collaborations and fundraising efforts, while maintaining
overall responsibility for corporate governance and human resources management. His leadership
ensures that Fallouh Healthcare
remains firmly focused on delivering transformative solutions to critical unmet needs in cardiac
care.
Adib Fallouh, Pharm. D. Commercial Director
- 15+ years pharmacy experience
- 10+ years pharmaceutical manufacturing
- Coordinates between funders, inventors, and pharmaceutical companies
Read More
Adib Fallouh serves as Commercial Director to Fallouh Healthcare, bringing extensive expertise in pharmaceutical development, commercial strategy, and healthcare operations. A qualified pharmacist with a Bachelor of Pharmacy (Hons), Adib has over 15 years of experience spanning retail pharmacy management, business development, and strategic consultancy roles within the healthcare sector. At Fallouh Healthcare, Adib provides strategic leadership across key areas including market access planning, operational scale-up, and commercialisation strategy. His insight into healthcare systems and patient-centred innovation helps shape the company’s long-term growth trajectory as it advances the PerDeCT device towards clinical adoption.
Shahida Liaqat, Project Manager
- 15+ years theatre lead
- Proven leadership skills within NHS
Read More
With over 15 years of hands-on experience as a theatre practitioner, Shahida brings deep clinical insight and proven leadership in surgical environments. Her strong foundation in theatre leadership, and management, and leading including relocations of services, rebuilding theatre teams along with expertise in clinical teaching, research and health technologies, positions her as a key force behind innovation at Fallouh Healthcare.
As Project Lead, Shahida oversees the planning and execution of critical milestones across research, development, and regulatory preparation for the PerDeCT device. Her structured, collaborative approach ensures that all technical, clinical, and operational workstreams stay aligned — keeping the company on track as it advances toward preclinical trials and regulatory approval.
Andrew Shortt B.Sc. M.Sc
- Innovation specialist in Medtech & Operation Funding
- HR & Operation workforce strategies, scaling & regulation
Read More
Andrew Shortt leads operations and human resources at Fallouh Healthcare, drawing on extensive experience across corporate, academic, and start-up environments in the life sciences and healthcare sectors. Holding a Master’s degree in Pharmacology, Andrew is responsible for project management, operational delivery, and organisational development, supporting the company’s growth as it advances the PerDeCT device towards clinical trials and commercialisation. He also oversees HR strategy, ensuring robust team development and governance frameworks as Fallouh Healthcare expands its activities across the UK and Europe.
Simon Manning, BA (Hon), Financial Director
- 20+ years accounting
- 10+ years supporting SMEs
Read More
With 30 years of experience in financial management, Simon oversees budgeting, financial modeling, growth projections, risk assessment, and financial reporting for complex projects.
He has direct experience managing Innovate UK projects for FHC and other pre-revenue SMEs, including grant budgeting and submissions.
Prof Tom Clutton-Brock, MBE, FRCP, FRCA, FFICM
- Professor of Anesthesia and Intensive Care Medicine at HRC-DDR & UHB
Read More
Professor Tom Clutton-Brock supports Fallouh Healthcare as a clinical advisor, providing specialist input on the clinical evaluation and regulatory strategy for the PerDeCT device. He is Professor of Anaesthesia and Intensive Care Medicine at the University of Birmingham and Director of the NIHR Trauma Management MedTech Co-operative, with extensive experience advising on the development and adoption of novel medical technologies.
Prof Bruno Podesser MBA, FA
- Professor of Cardiac Surgery at the Medical University of Vienna
- Director of the Center for Biomedical Research
Read More
Professor of Cardiac Surgery at the Medical University of Vienna and Director of the Center for Biomedical Research.
Prof Alexander Rothman, MA, MB BChir, PhD, MRCP
- Scientific Advisor & Technical Partner
Read More
Dr. Alexander Rothman advises Fallouh Healthcare on clinical validation and translational strategy for the PerDeCT device. He is a Clinical Senior Lecturer in Cardiovascular Medicine at the University of Sheffield and an Honorary Consultant Cardiologist, with expertise in early-phase clinical research and the development of innovative cardiovascular diagnostics.